dihydroergotamine has been researched along with Blood Loss, Surgical in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, H; Hoffmann, A; Horbach, T; Michaelis, HC; Schmidt, A; Wagner, W; Wolf, H | 1 |
Bachmann, F; Bohnet, J; Breyer, HG; Estoppey, D; Haas, S; Hochreiter, J; Jakubek, H; Leyvraz, P; Mair, J; Sorensen, R | 1 |
Koppenhagen, K; Mälzer, H; Matthes, M; Weber, U | 1 |
3 trial(s) available for dihydroergotamine and Blood Loss, Surgical
Article | Year |
---|---|
A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Topics: Aged; Anticoagulants; Blood Loss, Surgical; Dihydroergotamine; Drug Combinations; Factor Xa Inhibitors; Female; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Male; Middle Aged; Partial Thromboplastin Time; Phlebography; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Risk Factors; Safety; Thrombin Time; Thromboembolism; Thrombophlebitis | 1996 |
Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine.
Topics: Aged; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hip Prosthesis; Humans; Male; Prospective Studies; Thromboembolism; Thrombophlebitis | 1992 |
[Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
Topics: Adult; Aged; Aged, 80 and over; Blood Loss, Surgical; Dihydroergotamine; Drug Combinations; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Radionuclide Imaging; Risk Factors; Thrombophlebitis | 1991 |